[go: up one dir, main page]

WO2001076553A3 - Procede et dispositif d'administration transdermique renforcee de medicament - Google Patents

Procede et dispositif d'administration transdermique renforcee de medicament Download PDF

Info

Publication number
WO2001076553A3
WO2001076553A3 PCT/US2001/011120 US0111120W WO0176553A3 WO 2001076553 A3 WO2001076553 A3 WO 2001076553A3 US 0111120 W US0111120 W US 0111120W WO 0176553 A3 WO0176553 A3 WO 0176553A3
Authority
WO
WIPO (PCT)
Prior art keywords
drug
biological membrane
polysaccharide
permeability
drug delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/011120
Other languages
English (en)
Other versions
WO2001076553A2 (fr
Inventor
Samir S Mitragotri
Tuan A Elstrom
Scott C Kellogg
Joseph Kost
Linda Custer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sontra Medical Inc
Original Assignee
Sontra Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sontra Medical Inc filed Critical Sontra Medical Inc
Priority to AU2001251349A priority Critical patent/AU2001251349A1/en
Publication of WO2001076553A2 publication Critical patent/WO2001076553A2/fr
Publication of WO2001076553A3 publication Critical patent/WO2001076553A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne un procédé et un dispositif d'administration transdermique renforcée de médicament. Dans un mode de réalisation, le procédé comporte les étapes consistant à : (1) identifier une zone de membrane biologique ; (2) mettre en contact au moins un polysaccharide à perméabilité élevée avec la zone identifiée de membrane biologique ; (3) mettre en contact au moins un médicament avec la zone identifiée de membrane biologique ; et (4) transporter le ou les médicaments dans ou à travers la zone identifiée de membrane biologique. Dans un autre mode de réalisation, le procédé de transport renforcé de médicament dans ou à travers une membrane biologique comporte les étapes consistant à : (1) préparer un complexe renfermant le médicament et un polysaccharide à perméabilité élevée ; et (2) transporter le complexe dans ou à travers la membrane biologique. Selon une autre forme de réalisation, l'invention concerne un dispositif d'administration renforcée de médicament, qui comprend au moins un polysaccharide à perméabilité élevée et au moins un médicament. Le dispositif peut aussi comprendre une couche de contact qui est en contact avec la membrane biologique, et une couche intermédiaire contenant le(s) polysaccharide(s) à perméabilité élevée et le(s) médicament(s).
PCT/US2001/011120 2000-04-06 2001-04-06 Procede et dispositif d'administration transdermique renforcee de medicament Ceased WO2001076553A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001251349A AU2001251349A1 (en) 2000-04-06 2001-04-06 Method and device for enhanced transdermal drug delivery

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19504100P 2000-04-06 2000-04-06
US60/195,041 2000-04-06

Publications (2)

Publication Number Publication Date
WO2001076553A2 WO2001076553A2 (fr) 2001-10-18
WO2001076553A3 true WO2001076553A3 (fr) 2002-01-24

Family

ID=22719844

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/011120 Ceased WO2001076553A2 (fr) 2000-04-06 2001-04-06 Procede et dispositif d'administration transdermique renforcee de medicament

Country Status (2)

Country Link
AU (1) AU2001251349A1 (fr)
WO (1) WO2001076553A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110025770A (zh) * 2019-04-20 2019-07-19 长春生物制品研究所有限责任公司 一种稳定的重组人干扰素软膏及其生产方法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR042815A1 (es) * 2002-12-26 2005-07-06 Alza Corp Dispositivo de suministro de agente activo que tiene miembros compuestos
AU2015274237B2 (en) * 2014-06-11 2019-11-14 International Scientific Pty Ltd Device and method to treat or prevent joint degeneration
WO2020185053A2 (fr) * 2019-03-14 2020-09-17 주식회사 에스엔비아 Bande de micro-aiguilles présentant une activité améliorée pour favoriser la croissance des ongles des doigts et des orteils
KR102404662B1 (ko) * 2019-03-14 2022-06-02 주식회사 에스엔비아 활동성이 향상된 손톱 및 발톱 성장 촉진용 마이크로니들 밴드
DE102020200423A1 (de) * 2020-01-15 2021-07-15 Beiersdorf Aktiengesellschaft Verfahren zur Wirkstoffeinbringung in die Haut

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5423739A (en) * 1990-03-30 1995-06-13 Alza Corporation Device and method for iontophoretic drug delivery
WO1995028144A1 (fr) * 1994-04-13 1995-10-26 Ciba-Geigy Ag Systemes d'administration de medicaments, a liberation controlee dans le temps
US5470582A (en) * 1992-02-07 1995-11-28 Syntex (U.S.A.) Inc. Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles
WO1998029134A2 (fr) * 1996-12-31 1998-07-09 Altea Technologies, Inc. Formation de micropores sur un tissu pour l'administration d'agents bioactifs
WO1999044637A1 (fr) * 1998-03-06 1999-09-10 Spectrx, Inc. Technique et appareil permettant d'accroitre les debits d'un fluide dans un tissu biologique rendu microporeux
EP1060741A1 (fr) * 1999-06-14 2000-12-20 Epic Therapeutics, Inc. Microsphères à libération prolongée

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5423739A (en) * 1990-03-30 1995-06-13 Alza Corporation Device and method for iontophoretic drug delivery
US5470582A (en) * 1992-02-07 1995-11-28 Syntex (U.S.A.) Inc. Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles
WO1995028144A1 (fr) * 1994-04-13 1995-10-26 Ciba-Geigy Ag Systemes d'administration de medicaments, a liberation controlee dans le temps
WO1998029134A2 (fr) * 1996-12-31 1998-07-09 Altea Technologies, Inc. Formation de micropores sur un tissu pour l'administration d'agents bioactifs
WO1999044637A1 (fr) * 1998-03-06 1999-09-10 Spectrx, Inc. Technique et appareil permettant d'accroitre les debits d'un fluide dans un tissu biologique rendu microporeux
EP1060741A1 (fr) * 1999-06-14 2000-12-20 Epic Therapeutics, Inc. Microsphères à libération prolongée

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110025770A (zh) * 2019-04-20 2019-07-19 长春生物制品研究所有限责任公司 一种稳定的重组人干扰素软膏及其生产方法

Also Published As

Publication number Publication date
WO2001076553A2 (fr) 2001-10-18
AU2001251349A1 (en) 2001-10-23

Similar Documents

Publication Publication Date Title
WO1999054286A3 (fr) Inhibiteurs btk et leurs procedes d'identification et d'utilisation
WO2003012119A3 (fr) Procede d'amplification de l'acide nucleique
GB0301159D0 (en) System and method for searching,finding and contacting dates on the internet in instant messaging networks and/or in other metods
WO2003079882A3 (fr) Methode et systeme de determination d'un risque de debut de plaie
WO2002069586A3 (fr) Systeme, appareil et procede de messagerie instantanee basee sur la localisation
MXPA01010640A (es) Medicion y uso de interacciones moleculares.
TR200003193A3 (tr) Agir hidrokarbon beslemelerin islenmesi için yöntem ve aygit.
WO2003050661A3 (fr) Traitement de donnees
IS2866B (is) Magavarin ómeprasólörkorn, aðferð til að fá slík og lyfjaefnablöndur
AU4769900A (en) Nicotine delivery systems
EP1515282A3 (fr) Dispositif de stockage et système d'accès
HK1044966A1 (zh) C端蛋白标签
AU2002361129A1 (en) Information presenting substance-containing material, and identification method, identification system and identification device therefor
BR0005420B1 (pt) sistema de conector, e, conector.
WO2004016160A3 (fr) Nanoparticules polymeres redox
WO2002098355A3 (fr) Methodes et compositions pour diagnostic et traitement de la resistance a l'insuline et des etats associes
BR0115209A (pt) Eletrodo de difusão de gás
IL153880A0 (en) Method, apparatus, and system for network-based peer-to-peer business transactions
WO2001029881A3 (fr) Procede de fabrication de dispositif optoelectronique au moyen de plusieurs couches ecran anti-mordançage
EP1293779A3 (fr) Surface de biocapteur
WO2001076553A3 (fr) Procede et dispositif d'administration transdermique renforcee de medicament
WO2001051638A3 (fr) Enzymes de metabolisation de medicaments
AU1855401A (en) Screening method for candidate drugs
WO2001090334A3 (fr) Enzymes de metabolisation de medicaments
WO1997026867A3 (fr) Formes solides d'administration a liberation instantanee et leur procede de preparation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP